https://orcid.org/0000-0003-3691-4624
References
- Lin C-H, Lin H-S, Lin S-C, et al. Early improvement in PANSS-30, PANSS-8 and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia. Acta Psychiatr Scand. 2018;137:98–108. doi: 10.1111/acps.12849
- Østergaard SD, Foldger L, Mors O, et al. The validity and sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. Schizophr Bull. 2018;44:453–462. doi: 10.1093/schbul/sbx076
- Østergaard SD, Opler MGA, Correll CU. Bridging the measurement gap between research and clinical care in schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and other assessments based on the Simplified Negative and Positive Symptoms Interview (SNAPSI). Innov Clin Neurosci. 2017;14:68–72.
- Rasch G. Probabilistic models for some intelligence and attainment tests. Copenhagen: Danish Institute for Educational Research. Expanded Edition. Chicago: Chicago University Press; 1980.
- Bech P, Austin SF, Timmerby N, et al. A clinimetric analysis of a BPRS-6 scale for schizophrenia severity. Acta Neuropsychiatr. 2018;30:187–190. doi: 10.1017/neu.2017.40
- Sijtsma K, van der Ark LA. A tutorial on how to do a Mokken scale analysis on your test and questionnaire data. Brit J Math Stat Psy. 2017;70:137–158. doi: 10.1111/bmsp.12078
- Mokken RJ. Theory and practice of scale analysis. Berlin: Mouton; 1971.
- Bech P. Clinical Psychometrics. Oxford: Wiley-Blackwell; 2012.
- Østergaard SD, Papakostas GI, Fava M. Depression: response and remission. In: Price LH, Stolerman I, editor. Encyclopedia of psychopharmacology. Berlin Heidelberg: Springer-Verlag; 2015. p. 34–59.
- Park YC, Yang S-Y, Chong M-Y, et al. Differences in high dose antipsychotic prescriptions in patients with schizophrenia in Asian countries/areas: findings from the REAP-AP study. Psychiatry Investig. 2018;15:1007–1008. doi: 10.30773/pi.2018.09.06
- Park YC, Lee MS, Si TM, et al. Psychotropic drug-prescribing correlates of disorganized speech in Asians with schizophrenia: The REAP-AP study. Saudi Pharm J. 2019;27:246–253. doi: 10.1016/j.jsps.2018.11.006
- World Health Organization. The ICD-10 classification of mental and behavioral disorders, clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
- Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:779–812.
- Leucht S, Kane JM, Kissling W, et al. Clinical implications of Brief Psychiatric Rating scale scores. Br J Psychiatry. 2005;187:366–371. doi: 10.1192/bjp.187.4.366
- Leucht S, Engel RR, Davis JM, et al. Equipercentile linking of the Brief Psychiatric Rating scale and the clinical global impression scale in a catchment area. Eur Neuropsychopharmacol. 2012;22:501–505. doi: 10.1016/j.euroneuro.2011.11.007
- Guy W. ECDEU assessment manual for Psychopharmacology. US Department of Health, Education, and Welfare publication. Washington (DC): National Institute of Mental Health; 1976.
- Østergaard SD, Rothschild AJ, Flint AJ, et al. Establishing the cut-off score for remission and severity-ranges on the psychotic depression assessment scale. J Affect Disord. 2016;190:111–114. doi: 10.1016/j.jad.2015.09.073
- Kraemer HC. Assessment of 2×2 associations: Generalization of signal detection methodology. Am Statistician. 1998;42:37–49.
- Barch DM, Bustillo J, Gaebel W, et al. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res. 2013;150:15–20. doi: 10.1016/j.schres.2013.04.027
- Heckers S, Barch DM, Bustillo J, et al. Structure of the psychotic disorders classification in DSM-5. Schizophr Res. 2013;150:11–14. doi: 10.1016/j.schres.2013.04.039
- Sawamura J, Morishita S, Ishigooka J. Is there a linear relationship between the Brief Psychiatric Rating scale and the Clinical Global Impression-schizophrenia scale? A retrospective analysis. BMC Psychiatry. 2010;10:105. doi: 10.1186/1471-244X-10-105